Latest Videos |view all videos
A recent study co-authored by Mayo Clinic physicians and presented at the 2012 ACC Annual Scientific Session & Expo might change the way we assess obesity in individuals with heart disease.
Thom W. Rooke, M.D., a professor of medicine at Mayo Clinic's Gonda Vascular Center, provides information about fibromuscular dysplasia (FMD). Dr. Rooke highlights what FMD is, the problems it causes, treatments and resources available ...
Roger D. White, M.D., discusses his article of a case of out-of-hospital cardiac arrest with 96 minutes of continued pulselessness and relentless ventricular defibrillation.
Cardiologist Stephen Kopecky, M.D., discusses genetic testing that may allow physicians to predict the drugs and dosages most effective for patients with high cholesterol.
Body size, gender and the complexity of heart disease significantly influence how much cumulative radiation skin dose that patients receive during percutaneous coronary intervention (PCI) therapy, also known as angioplasty.
Thomas Moyer, Ph.D., from Mayo Clinic's Department of Laboratory Medicine and Pathology, offers background on the blood-thinner warfarin and why genetic variations in patients affect the dose that will be needed.
The collaborative approach and interdisciplinary culture of Mayo Clinic allowed for effective communication, rapid diagnosis and new protocols for heart and lung transplant recipients.